[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, the daily intake of atemoya juice does not change the pharmacokinetics of CYP1A2 substrates. Document [0] states that atemoya juice significantly inhibited CYP1A2 activity in human liver microsomes, but preadministration of atemoya had no effect on the pharmacokinetics of phenacetin, a CYP1A2 substrate, in rats. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]